Order:
  1.  7
    From “Inclusion in What” to “Equity in What”: (Re)Thinking the Question of In/Equity in Precision Medicine and Health.Alessia Costa, Jerome Atutornu, Tuba Bircan, Daniela Boraschi, Sasha Henriques, Richard Milne, Lydia Okoibhole, Christine Patch & Anna Middleton - 2024 - American Journal of Bioethics 24 (3):89-91.
    Precision medicine (PM) and genomics are increasingly scrutinized through the lens of health inequities. This is a welcome development for a field that, while concerned with health-related differen...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  2.  20
    What Difference Can Public Engagement in Genome Editing Make, and for Whom?Richard Milne, Ugbaad Aidid, Jerome Atutornu, Tuba Bircan, Daniela Boraschi, Alessia Costa, Sasha Henriques, Christine Patch & Anna Middleton - 2023 - American Journal of Bioethics 23 (7):58-60.
    Conley and colleagues (2023) explore how calls for broad public engagement (PE) in the case of heritable human genome editing are being put into action, reviewing the activities of five different i...
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  3.  10
    Ethical Challenges Associated with Pathogen and Host Genetics in Infectious Disease.Richard Milne & Christine Patch - 2022 - The New Bioethics 29 (1):24-36.
    The Covid-19 pandemic has demonstrated the potential of genomic technologies for the detection and surveillance of infectious diseases. Pathogen genomics is likely to play a major role in the future of research and clinical implementation of genomic technologies. However, unlike human genetics, the specific ethical and social challenges associated with the implementation of infectious disease genomics has received comparatively little attention. In this paper, we contribute to this literature, focusing on the potential consequences for individuals and communities of the use (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark